Purchase of surfactants and caffeine citrate for 2027
Original notice title
Achiziționarea Surfactanților și Cafeinei citrat necesare instituțiilor medico-sanitare publice pentru anul 2027
Opportunity Score
Why this score?
Opportunity
35 / 100
Complexity
40 / 100
Risk factors
No estimated value or budget provided; impossible to assess financial attractiveness.
Award criteria, eligibility requirements, and required documents are missing.
Submission deadline in 13 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Duration until Dec 2027
- Supply of surfactants (Beractantum) and caffeine citrate for public medical institutions in Moldova.
- Contract period of 365 days, likely covering the year 2027.
Show full summary
Open tender for the procurement of surfactants and caffeine citrate for public medical institutions in Moldova for 2027. Four lots, but only LOT-0001 (Beractantum) has a detailed description. Contract value and award criteria not disclosed. Electronic submission required in Romanian. Performance in Chișinău, Moldova.
Risks
No estimated value or budget provided; impossible to assess financial attractiveness.
Award criteria, eligibility requirements, and required documents are missing.
Submission deadline in 13 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Variants not allowed.
Administrative
- Electronic submission via Open portal
- Tenders must be submitted in Romanian language.
Requirements may be incomplete.
Buyer
Name
Centrul pentru Achiziții Publice Centralizate în Sănătate
Location
Chișinău, MDA
Identifier
1016601000212
Lots (4)
LOT-0001
Beractantum 25 mg/ml 4 ml
Surfactant for endotracheal instillation. Quantity: 190 vials. ATC R07AA30.
Location
Duration
Category
Deadline
Award details
Show original TED data
Original TED description
ATC R07AA30. Forma farmaceutică: Susp./instilație endotraheo-pulmonară. Mod de administrare: endotraheal. Unitatea de măsură: flacon. Cantitate: 190 flacoane.
LOT-0002
Caffeinum (Caffeinum citrat) 20 mg/ml
Pharmaceutical products. No detailed description available.
Location
Duration
Category
Deadline
Award details
Show original TED data
Original TED description
ATC N06BC01. Forma farmaceutică: soluție perfuzabilă și soluție orală. Mod de administrare: i/v. Unitatea de măsură: fiolă. Cantitate: 3708 fiole. Evaluarea ofertelor pentru lotul dat se realizează per mililitru, la prețul cel mai scăzut fără TVA, cu corespunderea tuturor cerințelor.
LOT-0003
Poractantum alfa 80 mg/ml 1.5 ml
Pharmaceutical products. No detailed description available.
Location
Duration
Category
Deadline
Award details
Show original TED data
Original TED description
ATC R07AA02. Forma farmaceutică: Susp./instilație endotraheo-pulmonară. Mod de administrare: endotraheal. Unitatea de măsură: flacon. Cantitate: 500 flacoane.
LOT-0004
Surfactantum 27 mg/ml 3 ml
ATC R07AA02. Forma farmaceutică: Susp./instilație endotraheo-pulmonară. Mod de administrare: endotraheal. Unitatea de măsură: flacon. Cantitate: 10 flacoane.
Location
Duration
Category
Award details
Procurement Details
- Publication date
- 08 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Romanian
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 393182-2026
- Source notice ID
- a94d8de5-0038-4edc-960a-c93076119706
Documents (2)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
35 / 100
Complexity
40 / 100
Risk factors
No estimated value or budget provided; impossible to assess financial attractiveness.
Award criteria, eligibility requirements, and required documents are missing.
Submission deadline in 13 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications